Richard Harty, MD
Gastroenterology · Oklahoma City, OKNPI 1205804457
Payments from drug & device makers
What this record shows
Every reported general payment came from a single manufacturer, Janssen Research & Development, LLC. That places this record below the midpoint for gastroenterology clinicians in OK, where the typical reported total is $4,832.
Across 5 payments — averaging $80.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$403
Across 66 payments — averaging $7208.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$333K
- Bristol Myers Squibb$126K
- Janssen Research & Development, LLC$17K
What the payments were for
- Travel & lodging$19849%
- Food & beverage$20551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 5 | $403 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$198
How this compares
$403 in reported general payments places this provider in the 15th percentile of 133 gastroenterology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 42 | $731 |
| Dicyclomine Hcl | 42 | $719 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Oklahoma City
- George SalemOklahoma City$1.2M
- Tauseef AliOklahoma City$536K
- Pooja SinghalOklahoma City$140K
- Hussein BitarOklahoma City$120K
- Trushar PatelOklahoma City$49K
- Matthew McBrideOklahoma City$33K
- Sanjay SikkaOklahoma City$31K
- Tony TranOklahoma City$11K
- Ahmad Al-TaeeOklahoma City$11K
- Sumit WaliaOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.